Antibodies under a microscope

PX-TA1216

Rovelizumab Biosimilar – Anti-ITGAL/ CD11a/ ITGB2/ CD18 mAb – Research Grade

Description

Rovelizumab Biosimilar - Anti-ITGAL/ CD11a/ ITGB2/ CD18 mAb - Research Grade

Target

ITGAL/ CD11a/ ITGB2/ CD18

Target Alias Name

Rovelizumab/Hu23F2G/ITGAL/ CD11a/ ITGB2/ CD18/anti-ITGAL/ CD11a/ ITGB2/ CD18

Isotype/Mimetic

IgG4-nd

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression